Bill Gates's fund will allocate $40 million for the Global Alliance for Livestock Veterinary Medicines (GALVmed), the public-private partnership which is based in Edinburgh, Great Britain.
GALVmed develops vaccines for the cattle, medicine and diagnostics, making them available for millions of poorest small farmers in Africa and the Southern Asia. Gates's fund also invests in agricultural innovative projects, including the Centre for Tropical Livestock Genetics and Health (CTLGH) which uses advanced technologies in genetics and animal breeding for improvement of productivity of livestock production in developing countries.
More than 1,3 billion people depend on cattle livestock. However, its breeding in developing countries becomes a difficult task. Animal diseases reduce farmers' income and can cause serious risks for human health, moreover a quarter of all animals that belong to poor farmers can't be treated and simply die.
Within the mission Gates's Fund helps farmers to lift their families out of poverty and contribute to the development of a sustainable global food system.
«Thanks to these investments into GALVmed we can use achievements of Great Britain in the field of research and development of capabilities to fight the spread of livestock diseases, as to protect animals in developing countries, and here, in Great Britain», — Bill Gates emphasized.
